Efficient Scale-up of Genetically Modified MSCs in Multiple Bioreactors.
This white paper addresses the challenge of scaling up cell therapy products from pre-clinical to clinical stages. With numerous products in R&D worldwide, developers need to optimize processes for treating individual patients. This involves selecting a larger culture system that replicates the desired product characteristics while meeting clean room and GMP standards.
Download our white paper to learn more on efficiently achieving large-scale 2D adherent cell cultures.
Fill out the form to access your white paper!
